The Division of Hematology conducts laboratory and clinical research. Our scientific and clinical research faculty and coordinators combine their energies to find “bench to bedside” solutions to improve the care and treatment of patients with hematologic disorders.
Ongoing scientific investigations include:
- the role of bone marrow cells in promoting tumor growth;
- anemia in the elderly;
- platelet development;
- myelodysplastic and myeloproliferative syndromes;
- anemia in HIV patients;
- treatment of sickle cell disease, and other blood diseases, particularly those that affect women, the elderly and minorities.
Working together, the physicians and scientists in the Brigham and Women’s Hospital Hematology Division continue the legacy of making clinical and scientific contributions to improve the care of individuals with hematological conditions.
The division’s current research funding is nearly $13 million. In addition to agency funding, the division is the beneficiary of four endowed funds: the Malcolm Hecht Jr. Hematology Research Fund, the Marc Levine Fund for Discovery, the Nehemias Gorin Foundation Hematology Endowed Fund, and the Tomasso Family Fellowship. Income from these endowments is fundamental to the success of our research and academic endeavors. The division’s current research funding is nearly $13 million. In addition to agency funding, the division is the beneficiary of four endowed funds: the Malcolm Hecht Jr. Hematology Research Fund, the Marc Levine Fund for Discovery, the Nehemias Gorin Foundation Hematology Endowed Fund, and the Tomasso Family Fellowship. Income from these endowments is fundamental to the success of our research and academic endeavors.
